ImmunologybioRxiv
An mRNA SARS-CoV-2 vaccine employing Charge-Altering Releasable Transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memory
O. Haabeth, J. Lohmeyer, A. Sallets…·R. Levy
This paper develops an mRNA SARS-CoV-2 vaccine using CARTs with a TLR-9 agonist, showing it induces neutralizing antibodies and T cell memory in mice.